Source:http://linkedlifedata.com/resource/pubmed/id/17593922
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2007-7-27
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
1743-4262
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
460-1
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
|
| pubmed:affiliation |
Pôle des Maladies, de l'Appareil Digestif, Hôpital Beaujon, Clichy, France. pascal.hammel@bjn.aphp.fr
|
| pubmed:publicationType |
Journal Article,
Comment
|